1. Home
  2. SNGX
  3. SNGX News

Latest Soligenix Inc. (SNGX) News on October 23, 2024

Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin
SNGX

PR Newswire

a day ago

Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin

Soligenix Invited to Present at Upcoming Investor Conferences
SNGX

PR Newswire

7 days ago

Soligenix Invited to Present at Upcoming Investor Conferences

HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer Conference
SNGX

PR Newswire

16 days ago

HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer Conference

SNGX: Marburg Outbreak Puts Focus on Soligenix Vaccine Development…
SNGX

Zacks Small Cap Research

20 days ago

SNGX: Marburg Outbreak Puts Focus on Soligenix Vaccine Development…

Soligenix Announces Partnership with Sterling Pharma Solutions
SNGX

PR Newswire

20 days ago

Soligenix Announces Partnership with Sterling Pharma Solutions

Nova Minerals and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
SNGX

ACCESSWIRE

a month ago

Nova Minerals and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Join Soligenix's Exclusive Live Investor Webinar and Q&A Session on September 18, 2024
SNGX

PR Newswire

a month ago

Join Soligenix's Exclusive Live Investor Webinar and Q&A Session on September 18, 2024

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
SNGX

ACCESSWIRE

a month ago

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

Soligenix Receives European Patent for Improved Production of Synthetic Hypericin
SNGX

PR Newswire

2 months ago

Soligenix Receives European Patent for Improved Production of Synthetic Hypericin

Soligenix and American Resources Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
SNGX

ACCESSWIRE

2 months ago

Soligenix and American Resources Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

SNGX: Phase 3 Trial of HyBryte™ in CTCL to Initiate in 2H24…
SNGX

Zacks Small Cap Research

2 months ago

SNGX: Phase 3 Trial of HyBryte™ in CTCL to Initiate in 2H24…

Soligenix Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
SNGX

Simply Wall St.

2 months ago

Soligenix Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Soligenix Announces Recent Accomplishments And Second Quarter 2024 Financial Results
SNGX

PR Newswire

2 months ago

Soligenix Announces Recent Accomplishments And Second Quarter 2024 Financial Results

SNGX

GlobeNewswire

3 months ago

Strong Clinical Momentum for Soligenix's HyBryte™ in Treating Cutaneous T-Cell Lymphoma; PCG Digital Exclusive with Dr. Brian Poligone

PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix's HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results
SNGX

GlobeNewswire

3 months ago

PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix's HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results

SNGX: Positive Interim Results for HyBryte™ in Investigator-Initiated Study in CTCL; Raising Valuation to $35…
SNGX

Zacks Small Cap Research

3 months ago

SNGX: Positive Interim Results for HyBryte™ in Investigator-Initiated Study in CTCL; Raising Valuation to $35…

SNGX

MT Newswires

3 months ago

Top Premarket Gainers

SNGX

MT Newswires

3 months ago

Sector Update: Health Care Stocks Mixed Late Afternoon

SNGX

MT Newswires

3 months ago

Soligenix Shares Rally Following Positive Trial Results in Early-Stage Lymphoma

Expanded HyBryte™ Treatment Demonstrating Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma
SNGX

PR Newswire

3 months ago

Expanded HyBryte™ Treatment Demonstrating Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma

Soligenix Announces Positive Clinical Results from a Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma
SNGX

PR Newswire

4 months ago

Soligenix Announces Positive Clinical Results from a Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma

A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference
SNGX

PR Newswire

4 months ago

A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference

SNGX: Valuation Change Based on Reverse Split…
SNGX

Zacks Small Cap Research

4 months ago

SNGX: Valuation Change Based on Reverse Split…

Lotto 6/49 - $64 million up for grabs in the next draw!
SNGX

CNW Group

4 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
SNGX

Simply Wall St.

4 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North
SNGX

AFP

4 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
SNGX

Simply Wall St.

4 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m
SNGX

Simply Wall St.

4 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week
SNGX

Barrons.com

4 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend
SNGX

Simply Wall St.

4 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued
SNGX

Simply Wall St.

4 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses
SNGX

Investor's Business Daily

5 months ago

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library
SNGX

Business Wire

5 months ago

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap
SNGX

Investor's Business Daily

5 months ago

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap

EnviroGold Global Closes First Tranche of Private Placement
SNGX

GlobeNewswire

5 months ago

EnviroGold Global Closes First Tranche of Private Placement

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)
SNGX

GuruFocus.com

5 months ago

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)

How markets digested hot jobs print: Top takeaways
SNGX

Yahoo Finance Video

5 months ago

How markets digested hot jobs print: Top takeaways

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders
SNGX

GlobeNewswire

5 months ago

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"
SNGX

PR Newswire

5 months ago

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"

Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
SNGX

ACCESSWIRE

5 months ago

Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Setting the Stage for Success: PRISM MarketView Highlights Soligenix's Promising HyBryte™ Replication Trial
SNGX

GlobeNewswire

5 months ago

Setting the Stage for Success: PRISM MarketView Highlights Soligenix's Promising HyBryte™ Replication Trial

Soligenix Announces Reverse Stock Split
SNGX

PR Newswire

5 months ago

Soligenix Announces Reverse Stock Split

Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting
SNGX

PR Newswire

5 months ago

Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting

Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
SNGX

PR Newswire

5 months ago

Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting

SNGX

MT Newswires

5 months ago

Sector Update: Health Care Stocks Retreat Late Afternoon

SNGX

MT Newswires

5 months ago

Soligenix Seeks Shareholders' Approval for Reverse Stock Split; Shares Fall

Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split
SNGX

PR Newswire

5 months ago

Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split

PRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the Horizon
SNGX

GlobeNewswire

5 months ago

PRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the Horizon

SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference
SNGX

PR Newswire

5 months ago

SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference

Soligenix Encourages Stockholders to Vote Prior to Annual Meeting
SNGX

PR Newswire

5 months ago

Soligenix Encourages Stockholders to Vote Prior to Annual Meeting

Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice
SNGX

PR Newswire

5 months ago

Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice

SNGX: Second Confirmatory Phase 3 Trial of HyBryte™ in CTCL to Initiate Before End of 2024…
SNGX

Zacks Small Cap Research

5 months ago

SNGX: Second Confirmatory Phase 3 Trial of HyBryte™ in CTCL to Initiate Before End of 2024…

Soligenix First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
SNGX

Simply Wall St.

5 months ago

Soligenix First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results
SNGX

PR Newswire

5 months ago

Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results

Soligenix to Present at Upcoming Conferences
SNGX

PR Newswire

6 months ago

Soligenix to Present at Upcoming Conferences

Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa
SNGX

PR Newswire

6 months ago

Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa

Soligenix Announces Pricing of $4.75 Million Public Offering
SNGX

PR Newswire

6 months ago

Soligenix Announces Pricing of $4.75 Million Public Offering

Why Is Penny Stock Soligenix Trading Higher On Monday?
SNGX

Benzinga

6 months ago

Why Is Penny Stock Soligenix Trading Higher On Monday?

FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection
SNGX

PR Newswire

6 months ago

FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection

SNGX: Agreement with EMA on Second Confirmatory Trial for HyBryte™…
SNGX

Zacks Small Cap Research

6 months ago

SNGX: Agreement with EMA on Second Confirmatory Trial for HyBryte™…

FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection
SNGX

PR Newswire

6 months ago

FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection

Soligenix Announces Agreement on the Design of a Second Confirmatory Placebo-Controlled Trial for HyBryte™ With the European Medicines Agency
SNGX

PR Newswire

7 months ago

Soligenix Announces Agreement on the Design of a Second Confirmatory Placebo-Controlled Trial for HyBryte™ With the European Medicines Agency

SNGX

Zacks Small Cap Research

7 months ago

SNGX: Discussions Continue with FDA Regarding Second Phase 3 Study for HyBryte™ in CTCL…

Soligenix Announces Recent Accomplishments and Year End 2023 Financial Results
SNGX

PR Newswire

7 months ago

Soligenix Announces Recent Accomplishments and Year End 2023 Financial Results

Soligenix Announces Formation of Behçet's Disease Medical Advisory Board
SNGX

PR Newswire

8 months ago

Soligenix Announces Formation of Behçet's Disease Medical Advisory Board

Twin Vee PowerCats Co. Announce Arrival of Avikus Engineers to Fort Pierce to Begin Work on Autonomous A.I. Technology Partnership
SNGX

ACCESSWIRE

9 months ago

Twin Vee PowerCats Co. Announce Arrival of Avikus Engineers to Fort Pierce to Begin Work on Autonomous A.I. Technology Partnership

Worksport Announces Expansion of B2B Dealer Network and Upcoming Availability on Amazon, eBay, Walmart Marketplaces
SNGX

GlobeNewswire

9 months ago

Worksport Announces Expansion of B2B Dealer Network and Upcoming Availability on Amazon, eBay, Walmart Marketplaces

Soligenix and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
SNGX

ACCESSWIRE

9 months ago

Soligenix and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Soligenix to Present at The Microcap Conference
SNGX

PR Newswire

9 months ago

Soligenix to Present at The Microcap Conference

Cyngn's Next-Gen DriveMod Kit Will Harness Nvidia AI Computers
SNGX

PR Newswire

9 months ago

Cyngn's Next-Gen DriveMod Kit Will Harness Nvidia AI Computers

Pegasus Digital Mobility Acquisition Corp. Receives Continued Listing Standard Notice from NYSE
SNGX

Business Wire

9 months ago

Pegasus Digital Mobility Acquisition Corp. Receives Continued Listing Standard Notice from NYSE

We Think Allied Gaming & Entertainment (NASDAQ:AGAE) Can Afford To Drive Business Growth
SNGX

Simply Wall St.

9 months ago

We Think Allied Gaming & Entertainment (NASDAQ:AGAE) Can Afford To Drive Business Growth

Ashland Place Completes 3-Aircraft Financing for Atalaya Capital Management and Crestone Air Partners
SNGX

PR Newswire

9 months ago

Ashland Place Completes 3-Aircraft Financing for Atalaya Capital Management and Crestone Air Partners

MARPAI HIRES JOHN POWERS AS PRESIDENT
SNGX

PR Newswire

9 months ago

MARPAI HIRES JOHN POWERS AS PRESIDENT

7 A-Rated Semiconductor Stocks to Buy in January
SNGX

InvestorPlace

9 months ago

7 A-Rated Semiconductor Stocks to Buy in January

SNGX

Zacks Small Cap Research

9 months ago

SNGX: Phase 2a Psoriasis Trial Achieves Clinical Success…

TLSA: First Phase II SPMS Patient Dosed
SNGX

Zacks Small Cap Research

9 months ago

TLSA: First Phase II SPMS Patient Dosed

FDA Grants Soligenix "Fast Track" Designation for Dusquetide in the Treatment of Oral Lesions of Behçet's Disease
SNGX

PR Newswire

9 months ago

FDA Grants Soligenix "Fast Track" Designation for Dusquetide in the Treatment of Oral Lesions of Behçet's Disease

bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
SNGX

ACCESSWIRE

10 months ago

bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

Quince Therapeutics to Participate at Investor Events in January 2024
SNGX

Business Wire

10 months ago

Quince Therapeutics to Participate at Investor Events in January 2024

Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis
SNGX

PR Newswire

10 months ago

Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis

BayFirst Financial Corp. Appoints Thomas G. Zernick as CEO and Names Robin Oliver as President, Effective January 1, 2024
SNGX

GlobeNewswire

10 months ago

BayFirst Financial Corp. Appoints Thomas G. Zernick as CEO and Names Robin Oliver as President, Effective January 1, 2024

Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease in Nonhuman Primate Models of Ebola and Marburg Viruses
SNGX

PR Newswire

10 months ago

Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease in Nonhuman Primate Models of Ebola and Marburg Viruses

5E Advanced Materials Commences Mining Operations at 5E Boron Americas Complex
SNGX

GlobeNewswire

10 months ago

5E Advanced Materials Commences Mining Operations at 5E Boron Americas Complex

Mingzhu Announces Unaudited Financial Results for the Six Months Ended June 30, 2023
SNGX

PR Newswire

10 months ago

Mingzhu Announces Unaudited Financial Results for the Six Months Ended June 30, 2023

SYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTD
SNGX

CNW Group

10 months ago

SYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTD

Spectaire Announces Integration Between AireCore™ and Geotab, Delivering Enhanced Emissions Monitoring
SNGX

GlobeNewswire

10 months ago

Spectaire Announces Integration Between AireCore™ and Geotab, Delivering Enhanced Emissions Monitoring

NeuroSense Reports New Data: Statistically Significant Clinical Efficacy in Phase 2b ALS Trial
SNGX

PR Newswire

10 months ago

NeuroSense Reports New Data: Statistically Significant Clinical Efficacy in Phase 2b ALS Trial

Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
SNGX

GlobeNewswire

10 months ago

Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)

Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow
SNGX

ACCESSWIRE

10 months ago

Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow

iClick Interactive Asia Group Limited Reports 2023 Half-Year Unaudited Financial Results
SNGX

PR Newswire

10 months ago

iClick Interactive Asia Group Limited Reports 2023 Half-Year Unaudited Financial Results

Adicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual Meeting
SNGX

Business Wire

10 months ago

Adicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual Meeting

Here's Why We Think Soligenix, Inc.'s (NASDAQ:SNGX) CEO Compensation Looks Fair
SNGX

Simply Wall St.

10 months ago

Here's Why We Think Soligenix, Inc.'s (NASDAQ:SNGX) CEO Compensation Looks Fair

Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers
SNGX

ACCESSWIRE

a year ago

Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers

TOP Ships Announces Increase in Shareholding by Pistiolis Family to 73% Via Full Conversion of Preferred Shares and Open-Market Purchases Demonstrating the CEO’S Commitment to the Company
SNGX

GlobeNewswire

a year ago

TOP Ships Announces Increase in Shareholding by Pistiolis Family to 73% Via Full Conversion of Preferred Shares and Open-Market Purchases Demonstrating the CEO’S Commitment to the Company

Phoenix To Demonstrate Battery Swap Technology for Commercial Vehicles
SNGX

ACCESSWIRE

a year ago

Phoenix To Demonstrate Battery Swap Technology for Commercial Vehicles

Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now
SNGX

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now

MARPAI, INC. CONFIRMS IT HAS FILED AN APPEAL TO NASDAQ DELISTING LETTER
SNGX

PR Newswire

a year ago

MARPAI, INC. CONFIRMS IT HAS FILED AN APPEAL TO NASDAQ DELISTING LETTER

"HyBryte™ Use in Early-Stage Cutaneous T-Cell Lymphoma" Published in Frontiers in Drug Discovery
SNGX

PR Newswire

a year ago

"HyBryte™ Use in Early-Stage Cutaneous T-Cell Lymphoma" Published in Frontiers in Drug Discovery

Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy
SNGX

GlobeNewswire

a year ago

Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy

Share on Social Networks: